Cuproptosis: New Mechanisms Linking Endothelial Dysfunction to Neurodegenerative Diseases and Therapeutic Prospects. [PDF]
Gu T, Wei X, Hua S.
europepmc +1 more source
FDX1 suppresses acute myeloid leukemia progression and reverses cuproptosis resistance via the ROS/p53/ME1 axis. [PDF]
Yao L +11 more
europepmc +1 more source
The ferroptosis-cuproptosis crosstalk in hematological malignancies: multi-omics insights into gene-regulated cell death and emerging therapeutic opportunities. [PDF]
Antal S +5 more
europepmc +1 more source
Cuproptosis in Ischemic Stroke: Molecular Mechanisms and Therapeutic Potential. [PDF]
Han X +5 more
europepmc +1 more source
Roles of cuproptosis in central nervous system tumors: from molecular mechanisms to therapeutic prospects. [PDF]
Li P, Gao Y, Liu W.
europepmc +1 more source
Cell death: immunogenic potential of cuproptosis in cancer. [PDF]
Galluzzi L, Kepp O, Kroemer G.
europepmc +1 more source
Cuproptosis and ferroptosis: signal pathways, diseases and therapeutic targets. [PDF]
Li YY, Tay FR.
europepmc +1 more source
Schisandrin B attenuates ischemic acute kidney injury in a CTR1-dependent manner by inhibiting cuproptosis. [PDF]
Lin L +6 more
europepmc +1 more source
ADSCs-Exo Attenuate HIRI in Miniature Pigs: Pharmacological Evidence for a Potential Association Between Copper-Associated Alterations and Ferroptosis-Related Responses. [PDF]
Lu X +6 more
europepmc +1 more source
KLHL20 protects against aldosterone-induced cardiomyocyte cuproptosis by promoting ubiquitination-mediated MR degradation. [PDF]
Hai J +11 more
europepmc +1 more source

